HCR — Health Issues
Skinny Labels, Big Savings Act (S 43). Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals (S 1096, HR 1843). Implementation of Inflation Reduction Act pricing proposal. Oversight and reform efforts affecting pharmacy benefit managers. Patent reform (S 1095, S 1097). Proposals related to drug shortages. Proposals related to pharmaceutical tariffs; Proposals related to drug pricing reform.
Lobbyists: MEGAN SUSSMAN HERBER (covered position: Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA) 2014-2018); mr ELLIOT VICE (covered position: Staff Assistant, Legislative Correspondent & Scheduler, Sen. Evan Bayh (D-IN) 2009-2010)
Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE